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Abstract
Intramuscular administration of plasmid DNA (pDNA) with non-ionic Pluronic block copolymers 
increases gene expression in injected muscles and lymphoid organs. We studied the role of 
immune cells in muscle transfection upon inflammation. Local inflammation in murine hind limb 
ischemia model (MHLIM) drastically increased DNA, RNA and expressed protein levels in 
ischemic muscles injected with pDNA/Pluronic. The systemic inflammation (MHLIM or 
peritonitis) also increased expression of pDNA/Pluronic in the muscles. When pDNA/Pluronic 
was injected in ischemic muscles the reporter gene, Green Fluorescent Protein (GFP) co-localized 
with desmin+ muscle fibers and CD11b+ macrophages (MØs), suggesting transfection of MØs 
along with the muscle cells. P85 enhanced (~4 orders) transfection of MØs with pDNA in vitro. 
Moreover, adoptively transferred MØs were shown to pass the transgene to inflamed muscle cells 
in MHLIM. Using a co-culture of myotubes (MTs) and transfected MØs expressing a reporter 
gene under constitutive (cmv-luciferase) or muscle specific (desmin-luciferase) promoter we 
demonstrated that P85 enhances horizontal gene transfer from MØ to MTs. Therefore, MØs can 
play an important role in muscle transfection with pDNA/Pluronic during inflammation, with both 
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inflammation and Pluronic contributing to the increased gene expression. pDNA/Pluronic has 
potential for therapeutic gene delivery in muscle pathologies that involve inflammation.
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Inflammation; gene delivery; ischemia; macrophage; plasmid DNA; Pluronic block copolymer; 
skeletal muscle transfection
Introduction
Direct intramuscular (i.m.) injection of naked plasmid DNA (pDNA) for skeletal muscle 
transfection was pioneered by J.A. Wolff in 1990 (1). As of today i.m. injection of pDNA 
makes up around 18% of worldwide gene therapy human clinical trials (2). These trials are 
related to DNA vaccines, Duchene muscular dystrophy, hind limb ischemia and cardiac 
ischemia (3–5). The i.m. injection of pDNA has shown excellent safety profiles, but low 
gene expression levels, which limits its use in various therapeutic applications. To overcome 
this limitation, we and others have proposed a very simple and inexpensive approach of co-
administering naked pDNA with non-ionic Pluronic block copolymers (“Pluronics” or 
“poloxamers”) that were shown to drastically increase the levels and duration of muscle 
gene expression (6, 7). Pluronics consist of non-ionic ethylene oxide (EO) and propylene 
oxide (PO) blocks arranged in a basic triblock A-B-A structure: EOx-POy-EOx. They do not 
form complexes with the pDNA (8). So far the mechanisms by which Pluronic increases the 
transfection with naked pDNA in skeletal muscles remained not well understood.
It has been known that skeletal muscles have a remarkable ability to regenerate after tissue 
injury, which coincides with the inflammatory events and presence of immune cells, in 
particular, macrophages (MØs). These cells play a key role in the process of skeletal muscle 
regeneration (9–13). Due to constant persistence throughout the inflammatory response, 
MØs help muscle membrane repair in a cell-to-cell contact dependent manner (14). 
Similarly, we know that direct i.m. injection of pDNA also triggers an inflammation 
response due to first, the physical injury caused by the needle, and second, the exposure to 
unmethylated CpG islands in bacterially derived pDNA. A previous study reported an 
increase in muscle transfection of pDNA during hind limb ischemia (15). It was already 
noted before that Pluronic effects pDNA expression in the muscle were lacking in immune-
deficient athymic mice, which implied the role of immune cells in muscle transfection (8). 
Moreover, co-administration of Pluronic with pDNA in the muscle greatly increased 
expression of the transgene along with the cDNA and mRNA levels in distal lymphoid 
organs, such as draining lymph nodes and spleen, with the transgene being co-localized 
there with antigen presenting cells (APCs) (16).
Most disease pathologies involve recruitment of inflammatory cells to the tissues and 
secretion of pro-inflammatory factors either locally or systemically. Since the therapeutic 
genes in the pDNA constructs are driven by constitutive cytomegalovirus (cmv) promoter 
with multiple NF-κb binding sites (17), inflammation may influence the gene expression. 
However, many studies involving i.m. injections of pDNA have been conducted in healthy 
muscles even when the ultimate goal was to use this method for therapeutic protein 
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expression in disease-affected tissues. Therefore, studies of the gene expression using 
relatively new platforms such as Pluronic block copolymers in various disease models will 
further help understanding the limits and opportunities for application of these platforms in 
gene therapy.
The aim of this study was to evaluate the effect of local and systemic inflammation on 
muscle gene expression after i.m. delivery of naked pDNA with or without Pluronics. To 
induce local inflammation, we used a murine hind limb ischemia model (MHLIM) and for 
systemic inflammation both MHLIM and peritonitis. In previous work, we ranked the 
potency of various Pluronics on the expression of a plasmid containing a luciferase reporter 
gene under the control of cmv promoter, and found that Pluronic P85 (P85) and SP1017 
were the most effective and safe (16). Here we examine the effects of these copolymers on 
the MØ ability to take up and express pDNA and horizontally transfer the transgene to the 
muscle cells both during in vitro coculture and adoptive transfer to healthy and disease 
affected animals.
Materials and Methods
Plasmids
The gWIZ™ high expression vectors encoding the reporter genes, luciferase (gWIZ™ Luc) 
and green fluorescent protein (GFP; gWIZ™ GFP), both under control of an optimized 
human cmv promoter followed by intron A from the cmv immediate-early gene were used 
throughout the study (Gene Therapy Systems, San Diego, CA). The pDRIVE5Lucia-
mDesmin and pDRIVE5GFP-mDesmin (InvivoGen, San Diego, CA) encodes luciferase and 
GFP reporter proteins respectively, transcribed under the control of murine desmin promoter 
for muscle-specific expression. All plasmids were expanded in E. coli DH5α and isolated 
using Qiagen’s EndoFree Plasmid Giga Kit (Qiagen, Valencia, CA) according to the 
supplier’s protocol, reconstituted in phosphate buffered saline (PBS) and stored at −20°C 
until use.
Block copolymers
Pluronic L61 (batch # WPNT-511B), P85 (batch # WPNT-511B), F127 (batch # 
WPNT-511B), were a gift of the BASF Co. (Mount Olive, NJ). A mixed composition of L61 
(0.25% w/v) and F127 (2% w/v), SP1017 (2.25% w/v) was obtained from Supratek Pharma 
Inc. (Montreal, Canada) or prepared using the corresponding copolymers.
pDNA/Pluronic formulations
The pDNA formulations were prepared as described (16) and used immediately for i.m. 
injections.
Cells
RAW264.7 immortalized mouse MØs cell line and C2C12 immortalized myoblasts (MBs) 
cell line were purchased from ATCC and cultured at 37°C and 5% CO2. To obtain 
terminally differentiated skeletal myotubes (MTs), C2C12 MBs were plated in 96-well 
plates (50,000 cells/well) in complete media (CM) containing Dulbecco’s minimal essential 
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media (DMEM) and 10% fetal bovine serum (FBS). After 24 h or ~100% confluence, CM 
was replaced with 200 µl/well differentiation media (DM) containing DMEM and 2% horse 
serum (HS) to facilitate fusion of MBs (18). DM was changed every 12 h thereafter until day 
5–10 when healthy long differentiated MTs were formed.
Animals
All animal experiments were carried out with approval of the University of Nebraska 
Medical Center (UNMC) and University of North Carolina at Chapel Hill (UNC-CH) 
Institutional Animal Care and Use Committee and in accordance with the NIH Guide for 
Laboratory Animal Use. Female Balb/c mice (6- to 8-weeks-old, Charles River 
Laboratories, Wilmington, MA) were used throughout this study. The animals were kept in 
groups of five and fed ad libitum.
Inflammation models and scheme of experiments
MHLIM was generated by surgical procedure as described (19, 20). Briefly, under general 
anesthesia, the femoral artery (FA) of right hind limb was completely excised after ligation 
at its proximal origin as a branch of the external iliac artery and before the point distally 
where it bifurcates into the saphenous and popliteal arteries. Saphenous artery and 
saphenous vein were also excised. An interval of 10 days was allowed for postoperative 
recovery before DNA administration in ischemic tibialis anterior (TA) muscle by direct i.m. 
injections. In some groups MHLIM surgery was performed on ipsilateral hind limb and test 
articles were simultaneously injected in contralateral TA muscles of the same mouse. 
Peritonitis was induced by intraperitoneal (i.p.) injections of filter-sterilized λ-carageenean 
(CGN; 1 mg/200 µl PBS) on the 1st and 2nd day and followed by test articles injections in 
TA muscles on the 3rd day. In some groups pDNA and Pluronic were in administered in 
separate legs in both healthy and peritonitis model.
pDNA injections
Animals were anesthetized by i.p. injection of mixed solution of ketamine (100 mg/kg) and 
xylazine (25 mg/kg) (Sigma, St. Louis, MO). Single injection of pDNA in 50 µl of Hank’s 
balanced salt solution (HBSS) alone or 50 µl of the block copolymer solution in HBSS was 
administered directly into right TA muscle of the mice using 28G 1 cc sterile syringe (BD 
Bioscience, Franklin Lakes, NJ).
Luciferase activity in vivo
Unless indicated otherwise mice were euthanized at the time points indicated in the figure 
legends and tissues were processed. The luciferase activity in 10 µl tissue homogenates was 
quantified using a TD20/20 or Glomax 20/20 luminometer (Promega, Fitchburg, WI) for an 
integration period of 20 s and 10 s respectively and normalized per mg of tissue as described 
before (16). Alternatively, luciferase activity was measured in live animals using in vivo 
imaging system IVIS-200 (Xenogen Corporation, Alameda, CA) 5 min after i.p injection of 
D-luciferin and the imaging data were quantified as described before (16).
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Polymerase Chain Reaction (PCR)—PCR and Reverse transcription PCR (RT-PCR) 
were performed as described in (16).
Percent White Blood Cell (WBC) count in blood samples
Fresh serial blood samples from the tail vein (30–40 µl), collected into EDTA coated 
capillaries by tail milking method, were analyzed in VetScanHM5 hematology analyzer 
(Abaxis Ltd, Union City, CA) and % WBC counts were plotted on a time scale (days) after 
ischemia surgery.
Tissue Histology
Muscle tissues [quadriceps (Q), adductor (A), gastrocnemius (G) and TA)] at specified time 
points were removed en bloc and processed as described earlier (16).
Adoptive transfer of GFP transfected MØs in ischemic mice
RAW 264.7 MØs were plated in vitro in T75 flask in macrophage colony stimulating factor 
(MCSF) supplemented CM for 24 h and transfected with gWIZ™ GFP pDNA using 
genePORTER300 transfection reagent as per supplier’s protocol (extrapolated from 60 mm2 
dish to T75 flask based on surface area). After another 24 h, 5×106 MØs were injected to 
ischemic mice by intrajugular vein injection (i.j.v.) 48 h post ischemic surgery. Ipsilateral 
ischemic and contralateral healthy muscle tissues were isolated 3 days after adoptive transfer 
of MØs (5 days post-surgery), embedded and frozen. 10 µm tissue sections were processed 
for immunohistochemistry (IHC) as described in (16).
Cytotoxicity evaluation
Cytotoxicity was determined using the CellTiter® 96 Aqueous Cell Proliferation Assay 
(MTS assay) (Promega, Fitchburg, WI) as per manufacturer recommendations. Briefly, cells 
(20,000 MØs, 16,000 MBs or day 7 MTs per well) were seeded in a 96-well plate 24 h 
before the experiment. Cells treated with Pluronic solutions in 100 µl of serum free media 
(SFM) for 2, 4, 6 and 8 h were rinsed thrice with SFM and cultured in CM. After another 24 
h, cells were incubated with a mixture of 100 µl SFM + 20 µl MTS assay reagent for 1 h at 
37°C at 5% CO2 and finally, calorimetric readout at 490 nm was done using Spectramax M5 
plate reader (Molecular Devices, Sunnyvale, CA). The results were expressed as the mean 
percentage cell viability relative to untreated cells ± SEM (n=6).
In vitro luciferase gene expression
To study the effects of P85 on gene expression, 500,000 MØs were plated in 24-well plates 
in antibiotic free media. 24 h later, cells were treated with mixture of gWIZ™ Luc in 
different concentrations of P85 in SFM for 2h, and cultured in CM. After another 24 h, 
luciferase activity was measured in cell lysates as described in (16). Luciferase activity in 
coculture experiments (below) was measured in 10 µl cell lysates (cmv-coculture model) or 
10 µl supernatant media (desmin-coculture model) using luciferase assay reagent or 
Quantiluc® respectively. The data was integrated over 10 s. Total protein content was 
measured using Pierce™ BCA Protein Assay Kit (Thermo-Fisher Scientific Inc, Waltham, 
MA) and data was expressed as RLU/mg protein.
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Gene expression in coculture
RAW 264.7 MØs were transfected with either gWIZ™ Luc or pDRIVE5Lucia-mDesmin 
plasmids using genePORTER® 3000 transfection reagent (Genlantis, San Diego, CA) as per 
supplier’s recommended protocol. Heparin sulfate washing disintegrates the polyion 
complexes of DNA and removes cell surface bound DNA lipoplexes or polyplexes (21–23). 
Therefore, to remove membrane bound complexes after transfection prior to coculture, 
transfected MØs were briefly rinsed with 1 mg/ml heparin sulfate solution in PBS, followed 
by two times rinse with PBS and this entire washing procedure was repeated twice. MØs 
were then resuspended in CM and 50,000 MØs were added on top of 50,000 MBs or MTs in 
each well. Exactly after 2 h when MØs adhere to MBs or MTs, the coculture was rinsed with 
SFM (thrice) to remove traces of serum and exposed to SFM with/without P85 (0.01%, 
0.1%, 0.3% and 1.0% w/v) for another 2 h, rinsed again with SFM (thrice) and cultured in 
280 µl CM. After 24 h, gene expression was analyzed as described above. To study time-
course of gene expression in coculture, the media was replaced every 12 h and samples were 
collected at the defined time points. For confocal imaging, gWIZ™ GFP or pDRIVE5GFP-
mDesmin plasmid were used. At different time points, post coculture samples were fixed 
and labeled as explained in immunocytochemistry (ICC) (see in Ref. (24)).
Western blotting
Cell lysates prepared using mammalian protein extraction reagent (M-PER®; Pierce 
Biotechnology, Rockford, IL) were mixed with 2× Laemmli sample buffer (Bio-Rad 
Laboratories, Hercules, CA), boiled for 5 min and separated on a precast 12% SDS-PAGE 
gel (Bio-Rad Laboratories, Hercules, CA). Proteins were transferred on PVDF membranes, 
blocked with 5% w/v skim milk and probed overnight (o/n) with antibodies against β-actin 
(Abcam, Cambridge, MA) and desmin (Abcam, Cambridge, MA) at 4°C with gentle 
shaking. Membranes were washed with tris-buffered-saline (TBS) containing 0.1% w/v 
tween and probed with goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology, Dallas, TX) 
and donkey anti-goat IgG-HRP (Abcam, Cambridge, MA) for 1 h at room temperature (RT) 
with gentle shaking before visualizing the protein bands using Pierce™ ECL Western 
Blotting substrate (Thermo Fisher Scientific, Waltham, MA).
Statistical analysis
As specified in legends to figures statistical comparisons were made using either unpaired 
Student’s t-test with Welch’s correction, or one-way ANOVA with Bonferroni correction 
for multiple comparison, multiple t-tests with Holm-Sidak correction for multiple 
comparisons.
RESULTS
Pluronic enhances gene expression during local inflammation in MHLIM
It was reported that co-injection of Pluronics with pDNA into the TA muscle of healthy 
animals increases and prolongs the gene expression compared to the naked pDNA (16). 
Here, to determine the effect of copolymers on the gene expression in the inflamed muscle 
of the disease-affected animal, we established and characterized MHLIM using previously 
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described procedures (19, 20). The ischemia and tissue inflammation in this model were 
validated by histological examination of various ischemic muscle sections (see Fig. 1 in Ref. 
(24)). This model shows a typical response consistent with inflammatory cellular infiltrate. 
The pDNA, with or without Pluronic (P85 or SP1017), was injected into ischemic TA 
muscle of MHLIM on day 10 after surgery (“ischemic muscle” injections). In parallel 
experiments, same pDNA formulations were injected in the healthy mice (“healthy muscle” 
injections). The expression of luciferase was determined in the muscle homogenates on day 
4 after injection, as previously described (8). The results suggested that P85 and SP1017 
increased the luciferase expression in a dose-dependent manner, revealing typical bell-
shaped dependencies of the expression vs. copolymer concentration, (Figs. 1a, b) in both 
ischemic and healthy muscles. However, there was a shift in the optimal concentration of 
Pluronic in the ischemic muscles, where the maximal expression was observed at higher 
concentration of the copolymers compared to the expression in the healthy muscles (0.6% 
vs. 0.3% w/v for P85 and 0.1% vs. 0.01% w/v for SP1017). At the maximum, in ischemic 
muscles, the expression levels of pDNA/copolymer mixtures were increased compared to 
the naked pDNA by ca. 72 fold for pDNA/P85 and 26-fold for pDNA/SP1017. Moreover, 
the maximal gene expression in ischemic muscles exceeded that in healthy muscles by ca. 8- 
and 3-fold for pDNA/P85 and pDNA/SP1017 respectively. Interestingly, the expression of 
naked pDNA also somewhat increased in ischemic muscles compared to that in healthy 
muscles.
We further determined the pDNA dose response on the gene expression by injecting 
different doses (5 µg, 10 µg and 50 µg) of naked pDNA or pDNA/Pluronic (SP1017, 0.1% 
w/v) into ischemic muscle. The results suggested that the optimal dose of pDNA/SP1017 
was 10 µg in 50 µl HBSS (Fig. 1c), and this dose was same as the one previously reported 
for healthy animals (8). At the lower dose of 5 µg, the levels of gene expression declined. At 
the higher dose of 50 µg, the gene expression leveled off and was not significantly different 
from that observed at 10 µg pDNA. Therefore, 10 µg pDNA was selected for further 
injections.
Next, the naked pDNA or pDNA/Pluronic was injected into ischemic and healthy muscles 
and the levels of luciferase pDNA and mRNA were determined 4 days after injection as 
previously described (16). The results suggested that Pluronic (SP1017, 0.1% w/v) increased 
pDNA and mRNA levels in healthy as well as in ischemic muscles compared to the animals 
injected with pDNA alone (Fig. 1d, f). Interestingly, the levels of DNA and mRNA in 
MHLIM injected with pDNA alone were considerably higher compared to these levels in the 
healthy animals (Fig. 1d, f).
Our previous studies showed that Pluronic prolongs transgene expression in the muscle of 
healthy Balb/c mice up to several weeks (6). Here we determined the time course of the 
luciferase expression in the ischemic TA muscle of MHLIM by quantifying luciferase 
bioluminescence in live animals (Fig. 1e) and (Fig. 2 in Ref. (24)). The areas under the 
curve (AUC) for the 60 days period were determined for each animal in all groups using the 
trapezoidal rule. When comparing the ischemic and healthy muscles injected with the naked 
pDNA, the former displayed much higher gene expression at every time point. Moreover, 
the gene expression was further significantly enhanced and prolonged when pDNA was 
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formulated with SP1017, resulting in increased exposure of the animal to the transgene by 
nearly an order of magnitude for at least 60 days (Fig. 2 in Ref. (24)). Thus, the AUC values 
in the MHLIM injected with pDNA/SP1017 and naked pDNA were ~2146 and ~570 
day*photons/s*106, respectively, suggesting ~ 3.8-fold increase in the transgene expression 
as a result of the pDNA formulation with SP1017. For comparison, in healthy animals the 
corresponding AUC values for pDNA/SP1017 and naked pDNA were ~449 and ~107 
day*photons/s*106 respectively. Statistical comparison of the AUC values for the pDNA/
SP1017 groups in the MHLIM and healthy animals suggest a significant difference between 
these groups (Fig. 1e).
The GFP reporter gene expression in ischemic TA muscles, harvested on day 4 after gWIZ™ 
GFP pDNA injection, was mainly seen in the muscle fibers located in and around the site of 
the injection, and co-localized with desmin muscle marker (see Fig. 3a in Ref. (24)). Also, a 
substantial GFP expression was observed in small punctate cells, uniformly spread 
throughout ischemic tissue section, and co-localized with CD11b MØ marker (see Fig. 3b in 
Ref. (24)). Interestingly, the number of GFP expressing CD11b+ MØs in ischemic muscles 
appeared to be much higher than previously reported by us in non-inflamed muscles of the 
same mouse strain (16). Moreover, we also observed a higher number of GFP expressing 
muscle fibers in ischemic muscles injected with pDNA/P85 compared to pDNA alone (see 
Fig. 4 and Fig. 5 in Ref. (24)).
Pluronic enhances gene expression in muscle during systemic inflammation
MHLIM was accompanied by systemic inflammation as evidenced by increase in 
neutrophils count in blood (Fig. 2a). Therefore, we examined the effect of inflammation 
during MHLIM on the transgene expression in the distal muscle. In this experiment the 
MHLIM was developed as described before, but the site of pDNA injection was spatially 
separated from the inflammation site (Fig. 2b). Naked pDNA alone or pDNA/Pluronic were 
injected in contralateral TA muscle simultaneously with the ischemia surgery performed on 
ipsilateral hind limb, and gene expression levels in muscles and draining lymph nodes were 
quantified in tissue homogenates at day 3. Consistent with our previous studies (8, 16) in 
healthy mice P85 increased gene expression compared to pDNA alone. The ischemia 
surgery in MHLIM resulted in a further increase in the expression, which was statistically 
significant in contralateral muscle (Fig. 2c) and displayed a trend in lymph nodes (Fig. 2d). 
Importantly, the effect of inflammation on gene expression was only observed with 
pDNA/P85 and not with pDNA alone. These effects appeared to be dependent on the type of 
the copolymer used since they were not statistically significant for the pDNA/SP1017 
although revealed similar trends, especially in the contralateral muscles (see Fig. 6 in Ref. 
(24)).
The effect of inflammation on Pluronic-mediated gene expression at a distal site was striking 
and led to another experiment using peritonitis model to confirm the generality of the 
observation. Similar to MHLIM, systemic inflammation in peritonitis mouse model was 
confirmed by quantifying percent WBCs by hematological analysis of serial blood samples 
from tail vein (Fig. 3a). In this experiment, in addition to pDNA alone and pDNA/P85 
groups, we included a group injected with P85 and pDNA in spatially different hind limb 
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muscles (Fig. 3b). Since effect of P85 was more pronounced, we did not use SP1017 in this 
experiment. Luciferase reporter gene expression was quantified by in vivo imaging after i.p. 
injection of D-luciferin substrate. In both Pluronic treatment groups the animals with 
peritonitis showed a trend to increase gene expression in the muscle compared to healthy 
animals (Fig. 3c). In the peritonitis animals the contralaterally injected P85 significantly 
increased gene expression of pDNA in ipsilateral muscle, although the effect was 
numerically greater when P85 and pDNA were codelivered (Figs. 3c, d). Healthy mice 
injected with naked pDNA in ipsilateral leg and P85 in contralateral leg (DNA, P85) 
showed gene expression levels similar to naked pDNA alone.
Pluronic enhances transfection of MØs with pDNA in vitro
Since in vivo study suggested colocalization of the reporter gene with MØs (see Fig. 3b in 
Ref. (24)), we examined whether Pluronics can enhance transfection of MØs with pDNA in 
vitro. To this end we exposed RAW 264.7 cells for 2 h to pDNA at various concentrations of 
P85 and quantified luciferase in cell lysates 24 h after the exposure. Addition of P85 to the 
media, at the concentration as low as 0.01%, resulted in enhancement of the gene expression 
(Fig. 4a). This effect increased as the copolymer dose increased and reached over 4 orders of 
magnitude at 1% P85 concentration when the gene expression levels nearly matched that 
observed using a commercial transfection kit, genePORTER® 3000. Moreover, at the higher 
dose of pDNA (10 µg) the gene expression with 1.0% w/v P85 exceeded that using 
genePORTER® 3000 transfection (Fig. 4b). Analysis of pDNA uptake in the cells showed 
higher pDNA uptake in MØs than muscle cells and marginal increase of pDNA uptake in 
MØs in the presence of P85 ((see Fig. 7 in Ref. (24)). No such increase in uptake was 
observed in cultured muscle cells with the addition of P85 (MBs or MTs).
Adoptive gene transfer to muscle by ex vivo transfected MØs
To examine whether MØs can transfer genes to ischemic animals, the RAW 264.7 MØs 
were transfected ex vivo with gWIZ™ GFP using genePORTER 3000 and adoptively 
transferred via jugular vein to MHLIM animals 24 h post transfection and 48 h post 
ischemia surgery. The lower hind limb muscles (ischemic and non-ischemic) were isolated 3 
days after MØs administration, sectioned and analyzed by confocal imaging for co-
localization of GFP with CD11b+ MØs and desmin+ muscle fibers. Firstly, we found that the 
ischemic muscles in contrast to non-ischemic muscles stained positive for the MØs cell 
surface marker Cd11b (Fig. 5). This suggested recruitment of MØs to ischemic muscles and 
not to non-ischemic muscles of MHLIM. We observed lower levels of muscle-specific 
marker (desmin) in ischemic muscle compared to non-ischemic muscle, which is typical for 
ischemia (25, 26). Notably, CD11b staining in the ischemic muscles localized closely to the 
desmin expressing muscle cells, which suggests that either MØs were in close proximity to 
muscle fibers or CD11b was transferred from MØs to muscle cells. Secondly, the GFP 
expression in ischemic tissues co-localized with desmin+ muscle fibers having typical 
elongated shape (Fig. 5). Larger ischemic muscle fibers clearly expressed GFP protein 
unlike non-ischemic control muscles. This suggested that MØs can transfer GFP gene or 
protein to the muscle cells, and along with the muscle cells can collectively represent a 
reservoir or conduit for the gene expression. This may also imply that cell-to-cell contacts 
play role in exchange of genes or proteins from MØs across the cell membranes to otherwise 
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hard to transfect skeletal muscle fibers. In the in vitro co-culture of the GFP-transfected 
MØs with muscle cells we observed unidirectional exchange of CD11b from MØs to the 
muscle cells followed by expression of the reporter gene in the muscle cells (see Fig. 8 and 
Fig. 9 in Ref. (24)). No transfer of desmin from muscle cells to MØs was observed. Our data 
was similar to other reports that describe bi/uni-directional exchange of membrane 
components as a general cell-to-cell communication amongst various cell types (27–29).
Pluronic enhances horizontal transfer of pDNA from MØs to muscle cells
After demonstrating that Pluronic can enhance the transfection of MØs with pDNA, we 
further examined whether it could also increase the pDNA transfer from the transfected 
MØs to muscle cells. To evaluate such possibility, we studied in vitro effect of P85 on the 
transgene expression in the coculture of transfected MØs with muscle cells. First we 
transfected the constantly multiplying RAW 264.7 MØs with pDNA [MØ+DNA] and then 
cocultured them on top of the monolayers of 1) either terminally differentiated C2C12 MTs 
(depicted herein [MØ+DNA]+MT), or 2) precursor MBs ([MØ+DNA]+MB). Notably, MTs 
display high level of expression of desmin, which is much lower in MBs (Fig. 6a). Thus we 
used two different plasmids, one with the constitutive (cmv) promoter, gWIZ™ Luc pDNA 
(same as the plasmid used above), and the other with the muscle specific-desmin promoter, 
pDRIVE5Lucia-mDesmin (to quantify the muscle specific gene expression). In both cases, 
the transfected MØs or the cocultures were exposed to different concentrations of P85 (0.01, 
0.1, 0.3, 1.0% w/v) for 2 h and the total gene expression was determined after 24 h and 
normalized to the total protein. Using the desmin-driven pDNA we observed relatively low 
levels of normalized gene expression in all cell systems - [MØ+DNA], [MØ+DNA]+MT, 
and [MØ+DNA]+MB (Fig. 6b). In the transfected MØs and [MØ+DNA]+MB coculture the 
gene expression was decreased at 1% P85 compared to respective copolymer-free controls. 
In contrast, [MØ+DNA]+MT coculture after exposure to the copolymer displayed a trend 
for a monotonous increase in the normalized gene expression, this increase becoming 
significant at 1% P85. At this copolymer concentration the total gene expression in [MØ
+DNA]+MT coculture was much higher than that in [MØ+DNA] and [MØ+DNA]+MB (see 
Fig. 10 in Ref. (24)).
Therefore, we further examined the gene expression in [MØ+DNA] and [MØ+DNA]+MT 
coculture at different time points after exposure to 1% P85 (Fig. 6c). In this case starting 
from day 2 there was a dramatic increase in gene expression in [MØ+DNA]+MT coculture 
but not in the transfected MØ alone. Compared to the coculture the level of gene expression 
in MØ+DNA was negligible with or without exposure to P85. The latter is probably 
explained by the promoter selectivity of the pDRIVE5Lucia-mDesmin plasmid used in this 
study as well by some toxicity of the 1% P85 to macrophages (see Fig. 11 in Ref. (24)). 
Notably, when similar co-culture experiments were carried out using constitutive (cmv) 
promoter driven gWIZ™ Luc pDNA, both the total and normalized gene expression in MØ
+DNA groups after 24 h was high ((see Fig. 12 and 13 in Ref. (24)). However, at later time 
points the normalized gene expression in MØ+DNA sharply decreased while in the 
coculture it increased, especially in the groups treated by P85 (see Fig. 12 in Ref. (24)). 
Using plasmids expressing GFP in the [MØ+DNA]+MT coculture groups, we were able to 
clearly see gene expression in the MTs (Fig. 6d) (see also Fig. 13c in Ref. (24)). This result 
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is particularly amazing given the fact that MTs are most difficult to transfect cells using 
normal cell transfection means (see Fig. 14 in Ref. (24)).
Discussion
Administration of pDNA to skeletal muscle is a strategy to deliver various genes for 
prophylactic and therapeutic purposes in healthy and diseased muscles (30–32). Currently, 
the application of direct i.m. pDNA injections is hindered by low levels of gene expression. 
Improvements in this area include electroporation-facilitated gene transfer known for its 
simplicity and use in human clinical trials (33). However, electroporation is associated with 
the risk of extensive and irreversible muscle damage induced by electrical pulses (34). This 
has limited its application in therapeutics, especially, when the goal is to rescue the muscle 
fibers during muscular pathologies, such as hind limb ischemia, polymyositis, muscular 
dystrophies, etc. Most of these pathologies involve inflammation and recruitment of 
inflammatory cells, which further contribute to tissue degeneration and muscle damage (35, 
36). We have reported that coadministration of pDNA with non-ionic amphiphilic Pluronic 
block copolymers leads to drastic increases in the level and duration of transgene expression 
in the healthy muscles (6, 37). In contrast to electroporation, muscle tissue did not appear to 
be affected by pDNA/Pluronic mixture as observed by histological analysis (16) and animals 
injected with these formulations did not show any signs of discomfort. Furthermore, 
Pluronic was coadministered with pDNA in the muscle during electroporation, where it 
alleviated the pulse-induced tissue damage and further increased the transgene expression 
(38).
Here, we report supplementary effects of Pluronic and inflammation caused by muscle 
ischemia on the transgene expression in the muscle. The greatest expression was observed in 
MHLIM when pDNA/Pluronic was injected directly in the ischemic muscle, although a 
significant increase compared to expression in healthy animals was also seen when the site 
of injection was distal from the ischemia site. The latter suggests that systemic inflammation 
contributes to the pDNA/Pluronic gene delivery in the muscle. This conclusion was also 
reinforced by an observed trend for increase in muscle transgene expression with pDNA/
Pluronic during systemic inflammation in the peritonitis model. Interestingly, the effects of 
Pluronic in peritonitis animals were higher when Pluronic was co-delivered with pDNA in 
the same muscle than upon their separate administration in different muscles. Still in the 
latter case gene expression in peritonitis model was increased possibly suggesting systemic 
distribution of Pluronic after intramuscular injection. In the absence of Pluronic 
inflammation had little if any effect on pDNA expression during peritonitis and relatively 
small effect in MHLIM. Notably, other studies also reported that inflammation could 
enhance muscle gene expression upon direct i.m. injection of naked pDNA (15, 39).
Previously published data suggested that Pluronics do not enhance muscle transfection in 
immune-deficient athymic nude mice (8, 40), which implied a mutually inclusive role of 
both immune cells and copolymers in the muscle transfection. We have also reported that 1) 
transgenes can be transferred from in vitro transfected MØs to the surrounding cells (e.g. 
neurons) upon coculture and 2) that after adoptive transfer, transfected MØs can deliver 
transgenes to the distal sites of inflammation, specifically to the brain in the mouse model of 
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Parkinsonism (41, 42). These studies suggested that transfected MØs can repackage pDNA 
and deliver across cell membranes to neuron cells via exosomes and other extracellular 
vesicles. The present study reinforces the idea that Pluronic may assist muscle transfection 
through the effects on immune cells and specifically MØs that are recruited in the inflamed 
muscles, pick up the pDNA and express the transgene. MØs are known to internalize 
bacterial derived pDNA by a very specific transport mechanism resulting in gene expression 
both in vitro (43) and in vivo (44). Here we demonstrate that treatment with Pluronic 
increases the transfection of MØs with naked pDNA and boosts gene expression up to 4 
orders of magnitude. Moreover, after adoptive transfer in MHLIM the transfected MØs are 
shown to deliver transgene to the ischemic but not the healthy muscles. These observations 
suggested that MØs can transfer transgene across the muscle cell membrane, and led to 
specific experiments using in vitro coculture models.
In these experiments we demonstrated that MØs can horizontally transfer pDNA to muscle 
cells and this process is greatly enhanced in the presence of Pluronic. Specifically we 
demonstrated the transfer of pDNA from MØs to MTs in vitro. Since MØs were transfected 
with pDNA bearing the muscle-specific promoter the enhanced gene expression in MTs 
could only result from pDNA transfer and not from the protein transfer. Using horizontal 
gene transfer with Pluronic we were able to efficiently transfect MTs that are terminally 
differentiated cells and therefore notoriously difficult to transfect in vitro. That is why 
researchers use transiently transfected mitotically active MBs and differentiate them to form 
transfected MTs. This procedure limits the skeletal muscle biology studies to early stages of 
muscle development. Our finding provides a novel approach for gene delivery to MTs at 
later stages (1–3 weeks) after differentiation and can find application in research labs.
Interestingly, we observed a unidirectional exchange of MØs cell surface marker (CD11b) to 
muscle cells but not vice versa (see Fig. 8 in Ref. (24)), which may explain the mechanism 
of delivering pDNA/protein across the membranes resulting in muscle cell transfection. 
Exchange of plasma membrane fragments, including cell-surface proteins and lipids, in 
conjugates formed between immune cells and their cellular partners is a field of intense 
investigation (45). This phenomenon may be in common with the evolutionary process, by 
which MØs recruited to the site of muscle damage deliver growth factors required for 
muscle regeneration. Recent studies have also reported a novel mechanism of vesicular 
exchange of protein/genetic material between APCs during cell-to-cell communication (46), 
which justifies our observations. It has been shown that immune cells can deliver RNA 
containing exosomes to an adjacent cell as soon as 10 minutes of establishing cell-to-cell 
contact (47). We have also reported that exosomes isolated from the media over transfected 
MØs can further transfect neuronal cells (41, 42).
Skeletal muscles are known for complex muscle biology, and recent studies have shown that 
MØs play a significant role in helping muscle regeneration and preventing muscle atrophy 
(9, 48–50) via cell-to-cell contacts (14). The role of stem and hematopoietic cells in muscle 
regeneration has been also extensively studied (51, 52). Evidence points to involvement of 
cell-to-cell fusion in muscle regeneration, whereby cells with stem cells’ properties fuse 
with damaged muscle fibers or satellite cells to form new muscle fibers. Technologies to 
deplete and repopulate specific cells including transgenic mice were developed and showed 
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that the stem cells with myeloid cell properties are responsible for muscle regeneration (13, 
53, 54). Similar mechanisms were reported for regeneration of liver by MØs fusion (55–57). 
Therefore, we posit a mechanism in which MØs are recruited to the sites of naked pDNA 
injections as a result of physiological insult caused by needle injury. These MØs 
phagocytose extracellular naked pDNA and then fuse with the existing muscles as a part of 
regeneration process thus, delivering pDNA into otherwise hard to transfect skeletal 
muscles. Based on our observations Pluronic can enhance both the transfection of the MØs 
with pDNA and the horizontal gene transfer from the transfected MØs to muscle fibers. 
Polyethylene glycol (PEG) mediated cell-to-cell fusion has been extensively studied since 
1970s to generate somatic cell hybrids for cloning, gene mapping, gene expression and 
antibody production (12, 58, 59). The proposed model involves exclusion of water 
molecules between lipid bilayers and changing the orientation of molecular dipoles that 
results in membrane fusion (60). Since Pluronics contain PEG as well as polypropylene 
glycol chains capable of incorporating into lipid membranes (61), we believe that they can 
enhance the MØs to muscle cell fusion events eventually delivering pDNA to muscle fibers 
and increasing transfection and gene expression both in healthy and inflamed muscles.
It is known that after direct i.m. injection in skeletal muscle naked pDNA is rapidly 
degraded in extracellular matrix (62, 63). Therefore, is noteworthy that we observed a block 
copolymer-dependent increase in pDNA copies in both healthy and ischemic muscles. 
Unlike cationic lipids or polycations, Pluronics are non-ionic molecules and do not form 
complexes with pDNA that can protect it from the degradation in the extracellular matrix 
similar to lipoplexes/polyplexes (16, 64). However, Pluronics can act as adjuvants that 
activate NF-κB cell signaling and increase pDNA uptake (65), pDNA nuclear import (66) 
and transcriptional activation of gene expression of pDNA delivered into cells in vitro with 
polyplexes (7, 67). It is well-known that inflammation results in increased blood neutrophils 
counts and secretion of pro-inflammatory cytokines like TNF alpha and IL-1β (68). The 
overall activation of inflammatory signaling can also influence cmv promoter driven gene 
expression and may explain somewhat increased gene expression of naked pDNA in non-
ischemic muscle of MHLIM. It is important to point out in this regard that the pDNA/
Pluronic expression in normal muscles was shown to be promoter selective and dependent 
on the NF-κB signaling pathway (8, 69). Moreover, systemic inflammation caused by 
ischemia resulted in increased number of circulatory MØs, which is consistent with previous 
studies (70, 71). This may result in increased MØs recruitment at the site of pDNA injection 
due to inflammatory response triggered by physical injury and exposure to bacterial CpG 
motif and ultimately increase muscle transfection with pDNA/Pluronic. We also observed 
increased transgene expression in draining lymph nodes, which was in agreement with our 
earlier studies using i.m. pDNA/Pluronic suggesting co-localization of transgene expression 
with APCs in lymphoid organs (16).
Altogether, MØs have gained recent attention for their promiscuity or plasticity to perform 
central roles in development, homeostasis and disease and have emerged as novel 
therapeutics target. Here we resolved a key issue of low muscle transfection in ischemic 
muscles by simple mixing of naked pDNA with Pluronic and showed how MØs assist gene 
transfer to otherwise hard to transfect skeletal muscle fibers. Since Pluronics are listed in 
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U.S. Pharmacopoeia and have been demonstrated to be safe in clinical trials (72) such 
formulations have promise for human use.
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Figure 1. Effect of co-formulation of pDNA with Pluronic on the transgene expression (a-c, e), 
DNA and RNA levels (d, f) in healthy and ischemic skeletal muscles
Luciferase expression (a-c, e) or DNA and RNA levels (d, f) in ischemic TA muscles of 
MHLIM (a-f) or normal TA muscles of healthy animals (a, b, d, e, f) after single injections 
of the pDNA, pDNA/P85, or pDNA/SP1017. (a-f) All injected solutions contained 10 µg 
gWIZ™ Luc pDNA in 50 µl HBSS with or without copolymers except (c) where the pDNA 
concentration was varied. (c-f) SP1017 concentration in injected solution was 0.1 % w/v. (a-
d, f) Measurements were done on day 4 by tissue sampling. (e) The AUC 0 to 60 days of the 
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time course of luciferase expression determined in live animals by quantifying the 
bioluminescence imaging data (see Fig. 2 in Ref. (24)) (a-c, e) Data are mean ± SEM (a-c) n 
= 5, pairwise comparisons using unpaired Student’s t-test with Welch’s correction * p < 
0.05, n.s. – not significant, (e) n = 3–4, the AUCs for each individual animal have been 
calculated and analyzed using one-way ANOVA with Bonferroni correction for multiple 
comparisons (f) Data are relative optical density of luciferase DNA or RNA levels presented 
in (d).
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Figure 2. Effect of skeletal muscle ischemia on transgene expression in contralateral muscles
(a) Changes in percent WBC counts in serial blood samples at different time points after 
ischemia surgery in MHLIM (solid lines, filled symbols) in comparison to healthy mice 
(dotted lines, open symbols). Day 0 corresponds to surgery. (b) Test articles were injected in 
TA muscles in healthy mice or in contralateral TA muscles simultaneously with the 
ipsilateral ischemia surgery in MHLIM. (c, d) Luciferase gene expression in the (c) TA 
muscles and (d) draining lymph nodes of MHLIM (black) and healthy mice (white) 3 days 
after single administration of 10 µg gWIZ™ Luc with or without 0.3 % w/v P85. Data are 
mean ± SEM (n = 3 (a) or n = 10 (c, d)), * p < 0.05, ***p<0.005, ****p<0.001, n.s. – non 
significant. (a) Statistical comparisons were made for Lymphocytes and Neutrophils in 
MHLIM and healthy mice using unpaired Student’s t-Test with Welch’s correction for 1 day 
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time point; (c, d) comparisons were made using one-way ANOVA with Bonferroni 
correction for multiple comparison.
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Figure 3. Effect of peritonitis on transgene expression in skeletal muscles
(a) Changes in percent WBC counts in serial blood samples at different time points after 
induction of peritonitis (solid lines, filled symbols) in comparison to healthy mice (dotted 
lines, open symbols, same group as in Fig. 2). Arrows indicate time points of CGN injections 
to induce peritonitis. Day 0 corresponds to the first injection. (b) Healthy mice or mice with 
peritonitis were injected in TA muscles with 10 µg gWIZ™ Luc pDNA alone, pDNA 
coformulated with 0.3 % w/v P85 or simultaneously injected in ipsilateral and contralateral 
TA muscles with pDNA and 0.3 % w/v P85. (c) Luciferase gene expression in pDNA 
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injected muscle of healthy (white bars) and peritonitis (black bars) mice was quantified 
using by quantifying the bioluminescence imaging data 4 days after pDNA administration. 
(d) Representative IVIS images used for quantification of gene expression data 4 days after 
pDNA administration. (a, c) Data are mean ± SEM (n=3), * p < 0.05, ** p < 0.01, n.s. - non 
significant. (a) Statistical comparisons were made for Lymphocytes and Neutrophils in 
healthy and peritonitis mice groups using unpaired Student’s t-Test with Welch’s correction 
for 1 day time point; (c) comparisons are made using one-way ANOVA with Bonferroni 
correction for multiple comparisons.
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Figure 4. Effect of Pluronic on the gene expression in RAW 264.7 MØs
(a, b) Cells were exposed to gWIZ™ Luc pDNA with or without P85 in SFM (a) for 2 h 
using 1 µg pDNA and various concentrations of P85 or (b) for 4 h using different amounts 
of pDNA (1 µg, 5 µg and 10 µg) and 1.0% w/v P85. (a, b) Cells transfected using 
genePORTER® 3000 transfection reagent are presented as positive control. Data were 
acquired using Glomax 20/20 luminometer or M5 Molecular Devices microplate reader. 
Data are mean ± SEM (n=4), * p<0.05, ** p<0.01, **** p<0.001 n.s. – non significant. 
Statistical comparisons were made for (a) treated vs. untreated groups or (b) otherwise 
indicated groups by one-way ANOVA with Bonferroni correction for multiple comparisons.
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Figure 5. In vivo transfection of muscle cells upon adoptive transfer of GFP transfected MØs
RAW 264.7 MØs transfected ex vivo with gWIZ™ GFP pDNA and administered i.j.v in 
MHLIM Balb/c mice (24 h after transfection, 48 h post ischemia surgery). Tissues (TA and 
G) were isolated 3 days thereafter and 10 µm thick sections of frozen tissues were processed 
for IHC. The color staining corresponds to nuclear DAPI (blue), GFP (green), CD11b (red) 
and desmin (magenta). The bottom panels present digitally superimposed images of 
preceding panels to visualize the co-localization (yellow or white). The images (20 ×) are 
representative of 3 sections per muscle and 3 mice per group. Scale bar = 50 µm.
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Figure 6. Effect of P85 on horizontal gene transfer from transfected MØs to muscle cells upon 
co-culture
(a) Increased desmin expression upon differentiation of MBs to day 7 MTs. (b, c) 
pDRIVE5Lucia-mDesmin transfected MØs were plated alone, [MØ+DNA], or cocultured 
with MBs, [MØ+DNA]+MB, or MTs, [MØ+DNA]+MT, and exposed to P85 (0.01, 0.1, 0.3 
and 1.0 % (b) or 1 % w/v (c)) for 2 h. Luciferase secreted in cell culture media was 
quantified after next 24 h (b) or at different time points. In the latter case (c) the media was 
replaced every 12 h and luciferase secreted in the media over 6 h period was determined 
daily until day 10. Data represents mean ± SEM, (b) (n=6), (c) (n=12). (b) Statistical 
Mahajan et al. Page 27
Biomaterials. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
comparisons were made using one-way ANOVA with Bonferroni correction for multiple 
comparisons (c) The AUCs for each individual condition are calculated and compared using 
one-way ANOVA with Bonferroni correction for multiple comparisons. * p<0.05, n.s. – non 
significant (d) GFP expression (green) in desmin+ MTs (cyan) was validated 3 days after 
their coculture with CD11b+ MØs (red) transfected with gWIZ™ GFP pDNA. Transfected 
MØs were placed on top of MTs. The confocal images were focused at MTs with MØs not 
visible. The last panels in each row present digitally superimposed images (20 ×) of 
preceding panels to visualize the co-localization (yellow). Scale bar = 50 µm.
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